Table 1 Characteristics of healthy control subjects and patients with lupus
HCs | Patients with SLE | |
|---|---|---|
Number | 48 | 53 |
Females/males, n | 43/5 | 49/4 |
Age, years | 37.5 (28.3–43.8) | 36.0 (30.0–43.0) |
Disease duration, years | 6.0 (1.0–11.0) | |
SLEDAI score | 6.0 (2.0–15.5) | |
SLEDAI <5, n | 25 | |
SLEDAI ≥5, n | 28 | |
Medications | ||
Medication-naïve, n | 7 | |
Prednisone, n | 46 | |
Prednisone dose, mean ± SD (mg/day) | 11.0 (5.0–22.5) | |
Immunosuppressive agent,a n | 13 | |